Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
15
Bearish filings
15
Named actors
12
Disclosed $ (bull / bear)
$3.6M / $136K
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-05-15 | Director Gordon Gary B. | bought | $25K | SEC ↗ |
| 2026-05-15 | Chief Financial Officer Patience David | bought | $17K | SEC ↗ |
| 2026-05-15 | CEO and President Szela Mary T | bought | $103K | SEC ↗ |
| 2026-05-15 | Director Stansky Michael P | bought | $500K | SEC ↗ |
| 2026-05-15 | Director Stansky Michael P | bought | $1.0M | SEC ↗ |
5 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-05-15 |
| Director Wahlstrom Mats |
| bought |
| $152K |
| SEC ↗ |
| 2026-05-15 | Chief Commercial Officer Marshak Richard | sold | $1K | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) First Light Asset Management, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-12 | 5%+ holder (13G) Utmost Group Plc | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-03-17 | CEO and President Szela Mary T | sold | $61K | SEC ↗ |
| 2026-03-16 | Chief Regulatory Officer Stevens Jennifer | sold | $3K | SEC ↗ |
| 2026-03-16 | Chief Commercial Officer Marshak Richard | sold | $2K | SEC ↗ |
| 2026-03-16 | Chief of Research Cox Bryan F. | sold | $2K | SEC ↗ |
| 2026-03-16 | Chief of Clinical Operations Devlin Jodi | sold | $1K | SEC ↗ |
| 2026-03-12 | Chief Regulatory Officer Stevens Jennifer | sold | $6K | SEC ↗ |
| 2026-03-12 | Chief Commercial Officer Marshak Richard | sold | $6K | SEC ↗ |
| 2026-03-12 | Chief of Research Cox Bryan F. | sold | $6K | SEC ↗ |
| 2026-03-12 | Chief of Clinical Operations Devlin Jodi | sold | $7K | SEC ↗ |
| 2026-03-11 | CEO and President Szela Mary T | sold | $18K | SEC ↗ |
| 2026-03-11 | Chief Regulatory Officer Stevens Jennifer | sold | $5K | SEC ↗ |
| 2026-03-11 | Chief Commercial Officer Marshak Richard | sold | $6K | SEC ↗ |
| 2026-03-11 | Chief of Research Cox Bryan F. | sold | $5K | SEC ↗ |
| 2026-03-11 | Chief of Clinical Operations Devlin Jodi | sold | $5K | SEC ↗ |
| 2026-02-23 | Director Stansky Michael P | bought | $1000K | SEC ↗ |
| 2026-02-23 | Director Stansky Michael P | bought | $481K | SEC ↗ |